| (210) | Number of the EPO application | 18791944 |
| (220) | Filing date of the EPO application | 2018.04.24 |
| (80) | EPO patent specification publication (B) | EPB nr. 48/2023, 2023.11.29 |
| (110) | EPO patent number | 3615057 |
| (21) | Number of the application | e 2020 0236 |
| (71) | Name(s) of applicant(s), code of the country | Alkahest, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | BRAITHWAITE Steven P., US;
CZIRR Eva, US;
GALLAGER Ian, US;
HUBER Nina, US;
MINAMI S. Sakura, US; |
| (73) | Name(s) of owner(s), code of the country | Alkahest, Inc., US; |
| (54) | Title of the invention | DOSING REGIMEN FOR TREATMENT OF COGNITIVE IMPAIRMENTS WITH BLOOD PLASMA PRODUCTS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/38 (2006.01.01); A61K 35/14 (2015.01.01); A61P 25/00 (2006.01.01); A61P 25/28 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2020.04.30 |
| (30) | Priority | 201762490519 P, 2017.04.26, US; 201762584571 P, 2017.11.10, US; 201862623468 P, 2018.01.29, US; 201862641194 P, 2018.03.09, US |
| (86) | International application | PCT/US2018/029189, 2018.04.24 |
| (87) | International publication | WO 2018/200560, 2018.11.01 |